Skip to main content

Month: March 2025

INVL Baltic Farmland plans to earn EUR 460 thousand net profit in 2025

The board of INVL Baltic Farmland, AB, a company investing in agricultural land, approved its activity forecasts for 2025. Consolidated revenues of INVL Baltic Farmland are forecasted at EUR 890 thousand and net profit should amount to EUR 460 thousand. These predictions are based on the assumption that during 2025 the value of the Company’s land holdings will not change. Also there will be no purchases or sales of land, and there will be no changes in provisions for receivables and no impact of tenant debts on the size of the administration fee. INVL Baltic Farmland and its subsidiaries own approximately 3,000 hectares of agricultural land in Lithuania which is rented out to agriculture companies and farmers. Additional information: INVL Baltic Farmland, a company that invests in agricultural land, announced its operating forecasts for...

Continue reading

Opus Genetics Announces Presentation on Phentolamine Ophthalmic Solution 0.75% in Dim Light Disturbances at World Cornea Congress IX

RESEARCH TRIANGLE PARK, N.C., March 21, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies for other ophthalmic disorders, today announced that a presentation featuring the LYNX-1 Phase 3 study of Phentolamine Ophthalmic Solution 0.75% in patients with dim light disturbances will be delivered this week at World Cornea Congress IX, taking place March 20-22, 2025 in Washington, D.C. Key highlights from the presentationAs previously reported, the LYNX-1 Phase 3 study met its primary endpoint, with a statistically significant greater percentage of Phentolamine Ophthalmic Solution 0.75%-treated participants gaining 15 or more letters of mesopic low contrast distance visual acuity...

Continue reading

Notice on the Decisions Adopted at the Ordinary General Meeting of Shareholders for 2025

We hereby inform you about the decisions adopted at the Ordinary General Meeting of Shareholders of Urbo Bankas UAB for 2025 (office address: Konstitucijos pr. 18B, Vilnius, company registration number 112027077, VAT number LT120270716) which was held on 21 March 2025 (please see the attached documents). For more information please contact: Julius Ivaška, Head of Business Division, tel. +370 601 04 453, e-mail media@urbo.ltAttachments1 annex_uaburbobankas-2024-12-31_financial statements2 annex_ independent auditors’s report3 annex_allocation of profit for 20244 annex_Urbo banko Article of AssociationResoliutions EN

Continue reading

Better Choice Company Shareholders Overwhelmingly Approve Acquisition of SRx Health Solutions and Related Proposals

TAMPA, Fla., March 21, 2025 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, is pleased to announce that the Company’s shareholders approved the following proposals (the “Proposals”) at the Company’s special meeting held today, March 21, 2025 (the “Meeting”):To authorize the issuance of up to 30,000,000 shares of Better Choice common stock in connection with a proposed arrangement (the “Arrangement”) with SRx Health Solutions, Inc., a corporation organized under the laws of the Province of Ontario (“SRx”), pursuant to which Better Choice will acquire SRx.To authorize the changing of the legal name of Better Choice from “Better Choice Company, Inc.” to “SRX Health Solutions, Inc.” and of the NYSE American ticker symbol from “BTTR” to “SRXH”.To...

Continue reading

Ferrellgas Partners, L.P. Announces CFO Retirement

LIBERTY, Mo., March 21, 2025 (GLOBE NEWSWIRE) — Ferrellgas Partners, L.P. (OTC: FGPR) (“Ferrellgas” or the “Company”), a technology enabled logistics company and nationwide distributor of propane and related products and services, announced today that Michael E. Cole, its Chief Financial Officer and Treasurer, has declared his intention to retire effective May 2, 2025. As previously reported, the Company retained Moelis & Company LLC to advise on various financial strategies and will continue this relationship while a search for a new CFO is undertaken. “Ferrellgas has benefited from the experience and leadership of Mike Cole,” said Tamria Zertuche, President and CEO for Ferrellgas. “Mike’s career spans multiple decades and has garnered Mike a vast portfolio of experience and knowledge in the finance and energy sectors....

Continue reading

United-Guardian Reports 2024 Financial Results

HAUPPAUGE, N.Y., March 21, 2025 (GLOBE NEWSWIRE) — United-Guardian, Inc. (NASDAQ:UG) reported that net sales and net income for FY 2024 increased compared to FY 2023. Net sales for the year increased by 12% from $10,885,154 in 2023 to $12,181,971 in 2024, generating net income of $3,250,875 ($0.71 per share) in 2024 compared to $2,581,370 ($0.56 per share) in 2023. Donna Vigilante, President of United-Guardian, stated, “We are pleased to announce that net sales and net income increased from 2023 to 2024. Sales of cosmetics ingredients and medical lubricants increased by 32% and 16%, respectively. The increase in cosmetic ingredient sales was primarily due to increased purchase orders from our largest distributor. Based on feedback from our distributor, the increase was due to greater demand for our products in China as a result...

Continue reading

Diana Shipping Inc. Becomes Strategic Partner in Two 7,500 cbm Semi-Refrigerated LPG Newbuildings

ATHENS, Greece, March 21, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that the Company agreed to become a strategic partner and invest in a newly established joint venture, Ecogas Holding AS, with an 80% equity interest in a transaction for the construction of two 7,500 cbm semi-refrigerated LPG newbuildings, with an option for two additional vessels. Delivery of the first vessel is expected in the first quarter of 2027 and of the second vessel in the fourth quarter of 2027. Diana Shipping Inc.’s fleet currently consists of 37 dry bulk vessels (4 Newcastlemax, 8 Capesize, 4 Post-Panamax, 6 Kamsarmax, 6 Panamax and 9 Ultramax). The Company also expects to take delivery of two methanol...

Continue reading

Clearmind Medicine’s FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones

Vancouver, Canada, March 21, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced today that its innovative drug candidate, CMND-100, has arrived in the United States following successful manufacturing. This marks a key milestone as the Company prepares to initiate its FDA-approved Phase I/IIa clinical trial for the treatment of Alcohol Use Disorder (AUD), a condition affecting over 28 million adults in the U.S. alone. CMND-100, a proprietary MEAI-based oral drug candidate, represents a potential breakthrough in AUD treatment, targeting the reduction of alcohol consumption and cravings through a...

Continue reading

Outcrop Silver Announces $5 Million Public Offering of Units, Led by Investment from Eric Sprott

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 21, 2025 (GLOBE NEWSWIRE) — Outcrop Silver & Gold Corporation (TSXV: OCG) (OTCQX: OCGSF) (DE: MRG) (“Outcrop Silver” or the “Company”) is pleased to announce that it has entered into an agreement with Research Capital Corporation as the sole agent and sole bookrunner (the “Agent”), in connection with a best efforts, public offering of units of the Company (the “Units”) for aggregate gross proceeds of up to $5,000,000 (the “Offering“) at a price of $0.22 per Unit. Mr. Eric Sprott, through 2176423 Ontario Ltd., has indicated his intention to participate in the Offering. Each Unit will be comprised of one common share of the Company (a “Common Share“) and one-half of one Common...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.